Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service
"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS
Ergebnis verändern
- Publikationstyp
Publikationstyp- Thema
- erschienen in
- Verlag
- Geographic terms
-
1
von Sedat Yildirim ; Ozlem Nuray Sever ; Ezgi Turkoglu ; et al.
Clinical Medicine Insights: Oncology, Vol 20 (2026)
Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
2
von Sila Oksuz ; Oguzcan Kinikoglu ; Ugur Ozkerim ; et al.
Journal of Cancer Research and Clinical Oncology, Vol 152, Iss 1, Pp 1-8 (2026)
Schlagworte: Gustave roussy immune score (GRIm score); Malignant melanoma; Nivolumab; Immunotherapy biomarkers; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
3
von Sedat YILDIRIM ; Özlem Nuray SEVER ; Goncagül AKDAĞ TOPAL ; et al.
Journal of Oncological Sciences, Vol 11, Iss 3, Pp 224-232 (2025)
Schlagworte: cdk4/6 inhibitors; metastatic breast cancer; palbociclib; ribociclib; progression-free survival; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- 4
-
5
Evolving treatment strategies for HER2-altered non–small-cell lung cancer: the rise of TKIs and ADCs
von Sevinc Balli ; Tugba Basoglu ; Mustafa Ozdogan
Frontiers in Oncology, Vol 16 (2026)
Schlagworte: antibody–drug conjugate; brain metastases; HER2-mutant NSCLC; resistance mechanisms; targeted therapy; tyrosine kinase inhibitor; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
6
von Özlem Nuray SEVER ; Tuğba BAŞOĞLU ; Şermin KÖKTEN ; et al.
Journal of Oncological Sciences, Vol 11, Iss 2, Pp 83-88 (2025)
Schlagworte: ductal carcinoma in situ; van nuys prognostic index; disease free survival; overall survival; radiotherapy; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
7
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
-
8
von Sedat Yıldırım ; Tugba Başoğlu ; Akif Doğan ; et al.
BMC Cancer, Vol 25, Iss 1, Pp 1-12 (2025)
Schlagworte: Triple negative breast cancer; HER2 status; Carboplatin; Neoadjuvant chemotherapy; Pathologic complete response; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
9
von İlknur Deliktaş Onur ; Oğuzcan Kınıkoğlu ; Gözde Kavgacı ; et al.
Acta Haematologica Oncologica Turcica, Vol 58, Iss 1, Pp 12-15 (2025)
Schlagworte: antibody-drug conjugates; adjuvant t-dm1; trastuzumab extensive; her2-positive breast cancer; Medicine (General); R5-920
-
10
von Oğuzcan Kınıkoğlu ; Yunus Emre Altıntaş ; Goncagül Akdağ ; et al.
Acta Haematologica Oncologica Turcica, Vol 58, Iss 1, Pp 40-45 (2025)
Schlagworte: colorectal cancer; metastasectomy; prognosis; survival outcomes; treatment planning; Medicine (General); R5-920
-
11
von İlknur Deliktaş Onur ; Mutlu Doğan ; Mehmet Akif Öztürk ; et al.
Current Oncology, Vol 32, Iss 11, p 639 (2025)
Schlagworte: dMMR colorectal cancer; MSI-H colorectal cancer; anti-EGFR; anti-VEGF; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
-
12
von Ugur Ozkerim ; Oguzcan Kinikoglu ; Sila Oksuz ; et al.
Medicina, Vol 62, Iss 1, p 99 (2026)
Schlagworte: HER2-positive metastatic colorectal cancer; CEA kinetics; systemic inflammatory markers; NLR; SII; first-line chemotherapy; Medicine (General); R5-920
-
13
von Yasar, Hatime Arzu ; Aktas, Burak Yasin ; Ucar, Gokhan ; et al.
In Clinical Genitourinary Cancer June 2024 22(3)
-
14
von Sedat Yildirim ; Akif Dogan ; Goncagul Akdag ; et al.
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Schlagworte: Early breast cancer; Neoadjuvant chemotherapy; Laboratory index; Pathologic complete response; Medicine; Science
-
15
von Telli, Tugba Akin ; Alan, Ozkan ; Demircan, Nazim Can ; et al.
In Orthopaedics & Traumatology: Surgery & Research May 2023 109(3)
-
16
von Ezgi Turkoglu ; Goncagul Akdag Topal ; Sedat Yıldırım ; et al.
Medicina, Vol 61, Iss 6, p 1075 (2025)
Schlagworte: Khorana Risk Score; venous thromboembolism; overall survival; metastatic gastric cancer; Medicine (General); R5-920
-
17
von Kınıkoğlu, Oğuzcan ; Altıntaş, Yunus Emre ; Yıldız, Anıl ; et al.
The Oncologist ; volume 30, issue 4 ; ISSN 1083-7159 1549-490X
-
18
von Heves Surmeli ; Deniz Isik ; Oguzcan Kinikoglu ; et al.
Pharmaceuticals, Vol 18, Iss 6, p 931 (2025)
Schlagworte: breast cancer; menopausal status; Trastuzumab Deruxtecan (TDM-1); treatment response; side effects; metastasis; Medicine; Pharmacy and materia medica; RS1-441
-
19
von Başoğlu, Tuğba ; Özgüven, Salih ; Özkan, Hülya Şahin ; et al.
In Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) May-June 2022 41(3):171-178
-
20
von Başoğlu, Tuğba ; Özgüven, Salih ; Şahin Özkan, Hülya ; et al.
In Revista Española de Medicina Nuclear e Imagen Molecular May-June 2022 41(3):171-178
-
21
von Alan, Ozkan ; Telli, Tugba Akın ; Basoğlu, Tugba ; et al.
In Neurocirugía January-February 2022 33(1):15-21
-
22
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
-
23
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
-
24
von Sila Oksuz ; Oguzcan Kinikoglu ; Ugur Ozkerim ; et al.
Medicina, Vol 61, Iss 5, p 819 (2025)
Schlagworte: HER2-positive breast cancer; trastuzumab emtansine; T-DM1; immunohistochemistry; progression-free survival; overall survival; Medicine (General); R5-920
-
25
von Telli, Tugba Akin ; Ozguven, Salih ; Alan, Ozkan ; et al.
Annals of Nuclear Medicine. 36(11):964-975
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag